AGT and early-onset autosomal dominant Alzheimer disease: Increasing evidence suggests that the peptide hormone angiotensin II (Ang-II), a primary RAS effector, contributes to neurodegenerative disorders such as Parkinson’s disease (PD) and Alzheimer’s disease (Arnold et al., 2013; Labandeira-García et al., 2014; Jackson et al., 2018).